Finnish Health Tech Company Alveos Develops Acoustic Sensing Method To Monitor Breathing Through Chest Vibrations

Alveos' new mechano-acoustic sensing approach aims to enable continuous, noninvasive respiratory monitoring in everyday situations.

Published on Feb. 13, 2026

Got story updates? Submit your updates here. ›

Health technology company Alveos has developed a new acoustic sensing method designed to monitor human breathing by detecting subtle chest vibrations and pressure changes, rather than using optical or airflow-based techniques. The approach is intended to support continuous, noninvasive respiratory monitoring in everyday situations, addressing limitations associated with common methods used in consumer wearables.

Why it matters

Respiratory rate and breathing patterns are increasingly recognized as indicators of physical exertion, stress, recovery and autonomic nervous system activity. However, continuous measurement in real-world conditions has remained technically challenging. Alveos' acoustic approach aims to provide a more robust and unobtrusive way to monitor breathing patterns outside of controlled clinical settings.

The details

Alveos' sensing system clips to clothing, with the sensor surface resting against the skin and maintained in stable contact using a magnetic clip, eliminating the need for adhesives or skin preparation. The method relies on high-sensitivity acoustic sensors to capture vibration patterns generated by airflow and chest wall motion during respiration, which are then processed on-device to characterize breathing rate, rhythm, and depth without the use of cameras, airflow masks, or optical measurements.

  • Alveos said it is planning a market launch for its product in the fourth quarter of 2026.
  • The company has completed pre-seed funding at a reported valuation of approximately €5 million.

The players

Alveos

A health technology company developing noninvasive methods for continuous respiratory monitoring, combining acoustic sensing, applied physiology, and data science to study how breathing patterns reflect physical and mental states in real-world contexts.

Patrick Obolgogiani

The chief executive officer of Alveos.

Got photos? Submit your photos here. ›

What they’re saying

“Our work builds on decades of research in respiratory physiology and acoustics. The challenge has been translating that science into a sensing modality that can operate continuously outside the clinic. By focusing on chest vibrations rather than optics or airflow, we are exploring a pathway that is both noninvasive and compatible with everyday use.”

— Patrick Obolgogiani, Chief Executive Officer, Alveos (pressreleasecc.com)

“Breathing is one of the few physiological functions that is both automatic and voluntarily adjustable. Our goal is to provide people with access to validated respiratory measurements that help them understand their breathing patterns, rather than relying on estimates or intermittent snapshots.”

— Patrick Obolgogiani, Chief Executive Officer, Alveos (pressreleasecc.com)

What’s next

Alveos said ongoing validation efforts are focused on ensuring the measurement robustness of its acoustic sensing method across different body types, activity levels, and environmental conditions.

The takeaway

Alveos' acoustic sensing approach represents an innovative step forward in enabling continuous, noninvasive respiratory monitoring that can function outside of controlled clinical settings, potentially providing users with valuable insights into their breathing patterns and overall health and wellness.